Basil T. Darras

22.3k total citations · 4 hit papers
269 papers, 8.0k citations indexed

About

Basil T. Darras is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Basil T. Darras has authored 269 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 145 papers in Genetics and 64 papers in Surgery. Recurrent topics in Basil T. Darras's work include Neurogenetic and Muscular Disorders Research (140 papers), Muscle Physiology and Disorders (63 papers) and RNA modifications and cancer (55 papers). Basil T. Darras is often cited by papers focused on Neurogenetic and Muscular Disorders Research (140 papers), Muscle Physiology and Disorders (63 papers) and RNA modifications and cancer (55 papers). Basil T. Darras collaborates with scholars based in United States, United Kingdom and Italy. Basil T. Darras's co-authors include Uta Francke, Darryl C. De Vivo, Richard S. Finkel, Seward B. Rutkove, Peter B. Kang, Jacqueline Montes, Eugenio Mercuri, H. Royden Jones, Jim S. Wu and Kathie M. Bishop and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Basil T. Darras

262 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Results from a phase 1 study of nusinersen (ISIS-SMN _Rx ) in children with spinal muscular atrophy

2016 460 citations Claudia A. Chiriboga, Basil T. Darras et al. Neurology profile →
Risdiplam in Type 1 Spinal Muscular Atrophy

2021 260 citations Giovanni Baranello, Basil T. Darras et al. profile →
Spinal muscular atrophy

2022 195 citations Eugenio Mercuri, Francesco Muntoni et al. profile →
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

2021 160 citations Basil T. Darras, Riccardo Masson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Basil T. Darras United States	49	4.8k	4.0k	2.2k	833	817	269	8.0k
John T. Kissel United States	46	3.8k 0.8×	2.6k 0.6×	1.5k 0.7×	381 0.5×	787 1.0×	129	7.2k
Kathryn J. Swoboda United States	48	4.5k 1.0×	4.3k 1.1×	2.3k 1.0×	337 0.4×	403 0.5×	152	7.4k
George W. Padberg Netherlands	46	5.9k 1.2×	2.5k 0.6×	1.1k 0.5×	416 0.5×	1.8k 2.2×	145	9.0k
Antonio Musarò Italy	49	6.3k 1.3×	1.8k 0.5×	1.1k 0.5×	717 0.9×	560 0.7×	158	8.8k
Kathryn R. Wagner United States	44	5.6k 1.2×	1.2k 0.3×	1.2k 0.5×	812 1.0×	1.2k 1.5×	123	7.4k
Mayana Zatz Brazil	49	6.2k 1.3×	2.1k 0.5×	1.2k 0.5×	373 0.4×	1.4k 1.7×	344	9.5k
Eugenio Parati Italy	46	4.5k 0.9×	2.2k 0.6×	913 0.4×	618 0.7×	232 0.3×	188	9.6k
Jerry R. Mendell United States	56	6.9k 1.4×	3.0k 0.7×	1.6k 0.7×	347 0.4×	909 1.1×	185	12.4k
Sonia Messina Italy	37	3.0k 0.6×	1.5k 0.4×	866 0.4×	359 0.4×	628 0.8×	114	4.3k
Rabi Tawil United States	61	9.8k 2.0×	2.5k 0.6×	1.0k 0.5×	722 0.9×	3.6k 4.4×	196	11.8k

Countries citing papers authored by Basil T. Darras

Since Specialization

Citations

This map shows the geographic impact of Basil T. Darras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basil T. Darras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basil T. Darras more than expected).

Fields of papers citing papers by Basil T. Darras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basil T. Darras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basil T. Darras. The network helps show where Basil T. Darras may publish in the future.

Co-authorship network of co-authors of Basil T. Darras

This figure shows the co-authorship network connecting the top 25 collaborators of Basil T. Darras. A scholar is included among the top collaborators of Basil T. Darras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basil T. Darras. Basil T. Darras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwon, Jennifer M., Francina Munell, Kotaro Yuge, et al.. (2025). Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nature Medicine. 32(2). 488–493.

Genetti, Casie A., Tanya Logvinenko, Leslie H. Hayes, et al.. (2025). Retrospective Cohort Analysis of Clinical, Molecular, and Histopathologic Characteristics of 275 Patients With Nemaline Myopathy. Neurology Genetics. 11(4). e200277–e200277.

Schroth, Mary, J. Deans, W. Bryan Burnette, et al.. (2024). Spinal Muscular Atrophy Update in Best Practices. Neurology Clinical Practice. 15(1). e200374–e200374. 5 indexed citations

Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2024). Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3. Neurology. 102(5). e209151–e209151. 19 indexed citations

Done, Nicolae, Edward Tuttle, Basil T. Darras, et al.. (2024). Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls. Muscle & Nerve. 70(1). 60–70. 11 indexed citations

McMillan, Hugh J., Giovanni Baranello, Michelle A. Farrar, et al.. (2024). Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy. Neurology. 104(2). e210268–e210268. 5 indexed citations

Abulí, Anna, et al.. (2023). The diagnosis communication process in spinal muscular atrophy: A cross-cutting view of the new challenges facing the therapeutic era. SHILAP Revista de lepidopterología. 1(1). 100825–100825. 1 indexed citations

Darras, Basil T., Giovanni Baranello, Odile Boespflug‐Tanguy, et al.. (2023). FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) (P7-9.009). Neurology. 100(17_supplement_2). 1 indexed citations

Gaki, Εleni, et al.. (2022). Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA. Journal of Neuromuscular Diseases. 10(1). 41–53. 4 indexed citations

10.

Servais, Laurent, Giovanni Baranello, Enrico Bertini, et al.. (2021). Pooled Safety Data from the Risdiplam Clinical Trial Development Program (4184). Neurology. 96(15_supplement). 3 indexed citations

11.

Tóth-Petróczy, Ágnes, Nikkola Carmichael, Elicia Estrella, et al.. (2019). Homozygous TRPV4 mutation causes congenital distal spinal muscular atrophy and arthrogryposis. Neurology Genetics. 5(2). e312–e312. 16 indexed citations

12.

Lipnick, Scott, Denis Agniel, Rahul Aggarwal, et al.. (2019). Systemic nature of spinal muscular atrophy revealed by studying insurance claims. PLoS ONE. 14(3). e0213680–e0213680. 53 indexed citations

13.

Montes, Jacqueline, Sally Dunaway Young, Elena Mazzone, et al.. (2018). Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. (P2.322). Neurology. 90(15_supplement). 4 indexed citations

14.

Kapur, Kush, et al.. (2018). Functional Mixed-Effects Modeling of Longitudinal Duchenne Muscular Dystrophy Electrical Impedance Myography Data Using State-Space Approach. IEEE Transactions on Biomedical Engineering. 66(6). 1761–1768. 8 indexed citations

15.

Rutkove, Seward B., Kush Kapur, Craig M. Zaidman, et al.. (2017). Electrical impedance myography for assessment of Duchenne muscular dystrophy. Annals of Neurology. 81(5). 622–632. 52 indexed citations

16.

Kirschner, Janbernd, Eugenio Mercuri, Richard S. Finkel, et al.. (2017). Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study. Neuropediatrics. 48.

17.

Connolly, Anne M., Julaine Florence, Mary Michaeleen Cradock, et al.. (2014). One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development. Pediatric Neurology. 50(6). 557–563. 39 indexed citations

18.

Boyden, Steven E., Genri Kawahara, Jennifer A. Myers, et al.. (2012). Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores. Neurogenetics. 13(2). 115–124. 57 indexed citations

19.

Glanzman, Allan M., Michael McDermott, Jacqueline Montes, et al.. (2011). Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy. 23(4). 322–326. 95 indexed citations

20.

Kaufmann, P., Richard S. Finkel, Basil T. Darras, et al.. (2007). G.P.2.01 The natural history of spinal muscular atrophy – preliminary results from the PNCR network. Neuromuscular Disorders. 17(9-10). 776–777. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact